BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  FDA Approves Manufacturing Plan for Menerba, BioNovo, Inc.'s Menopausal Hot Flash Drug Candidate

  September 23, 2010

   · 

  3 min read
• BioMidwest

  Adeona Pharmaceuticals to Host Investor Day on CNS Diseases

  September 23, 2010

   · 

  2 min read
• Drug Development

  India Approves Advaxis, Inc. Trial in Cervix Cancer

  September 23, 2010

   · 

  1 min read
• DiaGenic ASA: Updated Company Presentation

  September 23, 2010

   · 

  1 min read
• Pharm Country

  Abbott Laboratories Recalls Beetle-Tainted Similac Baby Formula

  September 23, 2010

   · 

  2 min read
• Alcon, Inc. Launches TobraDex(R) ST Suspension

  September 23, 2010

   · 

  1 min read
• Business

  BioMarin Pharmaceutical Inc. Appoints William Young and Kenneth Bate to Its Board of Directors

  September 23, 2010

   · 

  3 min read
• Business

  Abbott Laboratories and Reata Pharmaceuticals, Inc. Announce Agreement Worth at Least $450 Million to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.

  September 23, 2010

   · 

  4 min read
• Policy

  Johnson & Johnson to Congress-Motrin Buyback Was Legal, FDA Knew

  September 23, 2010

   · 

  1 min read
• Drug Development

  Data Published Today Reveal That Rigel Pharmaceuticals, Inc. and AstraZeneca PLC’s Novel Oral Therapy Fostamatinib Demonstrates Positive Response in Rheumatoid Arthritis Patients

  September 23, 2010

   · 

  6 min read